Emergent drug gets coveted FDA status

Emergent BioSolutions Inc., of Rockville, which develops and manufactures products that harness the immune system to treat and prevent disease, announced its BioThrax treatment for anthrax disease has been granted orphan drug status by the Food and Drug Administration for people with suspected or confirmed exposure to anthrax.

Leave a Reply

Your email address will not be published. Required fields are marked *